|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2-3
|
|
pubmed:dateCreated |
2002-6-13
|
|
pubmed:abstractText |
Thyroxine (T(4)) in supraphysiological doses has been found to be an effective supplemental treatment in open studies for refractory mood disorders. Unexpectedly, only minimal side effects have been reported. The goal of the present study was to investigate whether healthy controls and depressed patients differ in their ability to tolerate supraphysiological doses of T(4).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0165-0327
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
285-94
|
|
pubmed:dateRevised |
2009-9-28
|
|
pubmed:meshHeading |
pubmed-meshheading:12063156-Adult,
pubmed-meshheading:12063156-Adverse Drug Reaction Reporting Systems,
pubmed-meshheading:12063156-Antidepressive Agents,
pubmed-meshheading:12063156-Bipolar Disorder,
pubmed-meshheading:12063156-Depressive Disorder, Major,
pubmed-meshheading:12063156-Dose-Response Relationship, Drug,
pubmed-meshheading:12063156-Drug Therapy, Combination,
pubmed-meshheading:12063156-Female,
pubmed-meshheading:12063156-Humans,
pubmed-meshheading:12063156-Male,
pubmed-meshheading:12063156-Middle Aged,
pubmed-meshheading:12063156-Prospective Studies,
pubmed-meshheading:12063156-Reference Values,
pubmed-meshheading:12063156-Thyroid Function Tests,
pubmed-meshheading:12063156-Thyroxine,
pubmed-meshheading:12063156-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Effects of supraphysiological thyroxine administration in healthy controls and patients with depressive disorders.
|
|
pubmed:affiliation |
Department of Psychiatry, Klinikum Benjamin Franklin, Freie Universität Berlin, Berlin, Germany. mjbauer@mednet.ucla.edu
|
|
pubmed:publicationType |
Journal Article,
Evaluation Studies
|
